跳轉至內容
Merck
全部照片(1)

Key Documents

807473

Supelco

TOYOPEARL® DEAE-650M

phase DEAE (diethylaminoethyl), bottle of 250 mL, 65 μm particle size

同義詞:

TOYOPEARL® DEAE-650M Bulk Media

登入查看組織和合約定價


About This Item

分類程式碼代碼:
47101511

描述

DEAE-650M

形狀

slurry

特點

counter ion Cl-

包裝

bottle of 250 mL

參數

3 bar max. pressure

技術

HPLC: suitable

基質

methacrylate

基質活性組

DEAE (diethylaminoethyl) phase

粒徑

65 μm

工作pH值

2-10

容量

0.10 meq/mL±0.02 meq/mL ion exchange capacity
30 g/L±5 adsorption capacity (BSA)
30 mg/mL±5 mg/mL binding capacity (bovine serum albumin)

相容性

mode of use weak anion exchange chromatography

分離技術

anion exchange

一般說明

Toyopearl DEAE-650 resin is a weak anion exchanger for blood fractionation and other biomolecule purification. It can be used for high throughput capture, intermediate purification, and polishing process steps. If more powerful resolution is needed TSKgel DEAE-5PW resin should be used. Selectivity remains the same.

應用

TOYOPEARL® DEAE-650M is used in separation media and ion exchange resins. TOYOPEARL® DEAE-650M has been used in haemophilia studies.

規格

Clean in place with 0.5 M NaOH or 0.1 M HCl.

外觀

Shipped in 20% (v/v) ethanol.

推薦產品

Discover LiChropur reagents ideal for HPLC or LC-MS analysis

法律資訊

Toyopearl is a registered trademark of Tosoh Corporation

象形圖

Flame

訊號詞

Warning

危險聲明

危險分類

Flam. Liq. 3

水污染物質分類(WGK)

WGK 1

個人防護裝備

Eyeshields, Gloves, type N95 (US)


從最近期的版本中選擇一個:

分析證明 (COA)

Lot/Batch Number

未看到正確版本?

如果您需要一個特定的版本,您可以透過批號來尋找特定憑證。

已經擁有該產品?

您可以在文件庫中找到最近購買的產品相關文件。

存取文件庫

Masahiko Takanashi et al.
Journal of bioscience and bioengineering, 97(1), 78-81 (2005-10-20)
D(-)-3-hydroxybutyrate dehydrogenase (BDH; EC 1.1.1.30) from a poly(D(-)-3-hydroxybutyrate) (PHB) degrading bacterium, Acidovorax sp. SA1, was purified using Toyopearl DEAE-650M, red-Sepharose CL-4B, and Q Sepharose FF. The molecular mass of the enzyme was estimated as 27 kDa by SDS-PAGE and 110
P R Foster et al.
Vox sanguinis, 86(2), 92-99 (2004-03-17)
The risk of haemophiliacs contracting variant Creutzfeldt-Jakob disease (vCJD) via treatment with factor VIII concentrates is not known. Therefore, in order to determine the extent to which the vCJD agent might be removed during the preparation of factor VIII concentrate
Christine Machold et al.
Journal of biotechnology, 117(1), 83-97 (2005-04-16)
Two different approaches of matrix assisted refolding have been evaluated and compared to conventional refolding by dilution. Bovine alpha-lactalbumin was used for the studies as model protein. It was adsorbed under denaturing conditions on an ion exchange matrix and refolding
Günter Iberer et al.
Journal of chromatography. A, 972(1), 115-129 (2002-10-25)
Preparative continuous annular chromatography, a method to separate proteins in a truly continuous manner, was investigated in an industrial environment. Plasma-derived clotting factor IX concentrate was used as model protein. Separation of vitronectin, a common impurity in commercial available factor

我們的科學家團隊在所有研究領域都有豐富的經驗,包括生命科學、材料科學、化學合成、色譜、分析等.

聯絡技術服務